Huguet Jorge, Monllau Vanesa, Sabaté Sergi, Rodriguez-Faba Oscar, Algaba Ferran, Palou Juan, Villavicencio Humberto
Urology Department, Fundació Puigvert, Barcelona, Spain.
Eur Urol. 2008 Apr;53(4):785-92 discussion 792-3. doi: 10.1016/j.eururo.2007.06.045. Epub 2007 Jul 5.
We evaluated incidence, diagnosis, risk factors, and outcome of urethral recurrences (URs) following radical cystectomy in men with bladder urothelial carcinoma (UC).
Between 1978 and 2003, a total of 729 male patients underwent radical cystectomy for UC. We determined UR presentation mode and diagnosis. UR was analysed by multivariate analyses according to clinical and pathological risk factors. We evaluated the relative influence of bladder versus urethral pathology on overall survival.
A total of 34 URs (4.6%) were identified. Previous history of non-muscle-invasive bladder cancer (NMIBC) (p=0.005), NMIBC pathological subgroup (pTis, pTa, pT1) (p=0.038) and prostate tumor involvement (p=0.0001) in cystectomy specimens were independent predictors of UR. URs developed in 5 (2.2%) of 219 cases with orthotopic diversion and in 29 (5.6%) of 510 with cutaneous diversion (p=0.073). The difference could be explained by patient selection. Cutaneous diversion group had more patients at risk of UR: more cases with prostate tumor involvement (p=0.026) and with a history of NMIBC (p=0.009). Neither bladder nor urethral pathology showed any superiority as a predictor of overall survival.
Previous history of NMIBC, and also NMIBC and prostate tumor involvement in cystectomy specimen were predictors of UR. The lower incidence of UR in patients with orthotopic diversion could be a result of patient selection. Bladder tumor, UR, and even an upper urinary tract tumor could have been the cause of death in these patients.
我们评估了男性膀胱尿路上皮癌(UC)患者根治性膀胱切除术后尿道复发(UR)的发生率、诊断、危险因素及预后。
1978年至2003年间,共有729例男性患者因UC接受了根治性膀胱切除术。我们确定了UR的表现方式和诊断。根据临床和病理危险因素,通过多因素分析对UR进行分析。我们评估了膀胱与尿道病理对总生存的相对影响。
共识别出34例UR(4.6%)。既往非肌层浸润性膀胱癌(NMIBC)病史(p=0.005)、NMIBC病理亚组(pTis、pTa、pT1)(p=0.038)以及膀胱切除标本中前列腺肿瘤受累(p=0.0001)是UR的独立预测因素。219例原位尿流改道患者中有5例(2.2%)发生UR,510例皮肤尿流改道患者中有29例(5.6%)发生UR(p=0.073)。这种差异可通过患者选择来解释。皮肤尿流改道组有更多患者有UR风险:更多病例有前列腺肿瘤受累(p=0.026)和NMIBC病史(p=0.009)。膀胱和尿道病理作为总生存的预测指标均未显示出任何优势。
既往NMIBC病史以及膀胱切除标本中NMIBC和前列腺肿瘤受累是UR的预测因素。原位尿流改道患者中UR发生率较低可能是患者选择的结果。膀胱肿瘤、UR甚至上尿路肿瘤可能是这些患者的死亡原因。